# Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

> **NCT01893320** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 66 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Vosaroxin
- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT01893320
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-18
- **Primary completion:** 2021-01-11
- **Final completion:** 2021-01-11
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893320, "Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01893320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*